Armata Pharmaceuticals, Inc.
ARMP- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000921114
No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Armata Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 28 | 36 | +8 |
| Shares | 759.7K | 1.25M | +487.9K (+64.2%) |
| Value | $2.27M | $7.85M | +$5.58M (+245.5%) |
New holders (12)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 683 Capital Management, LLC | 139,860 | $878.3K | 0.07% |
| Goldman Sachs Group Inc | 45,163 | $283.6K | 0.00% |
| Omers Administration Corp | 28,125 | $176.6K | 0.00% |
| Millennium Management LLC | 26,088 | $163.8K | 0.00% |
| Susquehanna International Group, LLP | 24,360 | $153.0K | 0.00% |
| Qube Research & Technologies Ltd | 23,356 | $146.7K | 0.00% |
| Jane Street Group, LLC | 17,153 | $107.7K | 0.00% |
| Citadel Advisors LLC | 10,786 | $67.7K | 0.00% |
| Dauntless Investment Group, LLC | 6,131 | $38.5K | 0.14% |
| BNP Paribas Arbitrage, SA | 710 | $4.46K | 0.00% |
| Whittier Trust Co | 100 | $587 | 0.00% |
| Geneos Wealth Management Inc. | 92 | $578 | 0.00% |
Sold out (4)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Group One Trading, L.P. | 3,000 | $8.94K |
| Salem Investment Counselors Inc | 100 | $298 |
| JPMorgan Chase & Co | 24 | $72 |
| Barclays PLC | 6 | $18 |